Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Gains from Sales and Divestitures (2017 - 2025)

Chemours has reported Gains from Sales and Divestitures over the past 9 years, most recently at $3000.0 for Q4 2025.

  • Quarterly results put Gains from Sales and Divestitures at $3000.0 for Q4 2025, down 99.13% from a year ago — trailing twelve months through Dec 2025 was $3000.0 (down 99.13% YoY), and the annual figure for FY2025 was $3000.0, down 99.13%.
  • Gains from Sales and Divestitures for Q4 2025 was $3000.0 at Chemours, down from $343000.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for CC hit a ceiling of $410000.0 in Q4 2023 and a floor of $3000.0 in Q4 2025.
  • Median Gains from Sales and Divestitures over the past 5 years was $213000.0 (2022), compared with a mean of $218200.0.
  • Biggest five-year swings in Gains from Sales and Divestitures: surged 92.49% in 2023 and later crashed 99.13% in 2025.
  • Chemours' Gains from Sales and Divestitures stood at $122000.0 in 2021, then skyrocketed by 74.59% to $213000.0 in 2022, then surged by 92.49% to $410000.0 in 2023, then decreased by 16.34% to $343000.0 in 2024, then crashed by 99.13% to $3000.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $3000.0 (Q4 2025), $343000.0 (Q4 2024), and $410000.0 (Q4 2023) per Business Quant data.